6Stevens DA,Kan VL,Judson MA,et al.Practice guidelines for diseases caused by Aspergillus.Infectious Diseases Society of America.Clin Infect Dis,2000,30:696-709.
7Ascioglu S,Rex JH,de Pauw B,et al.Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants:an international consensus.Clin Infect Dis,2002,34:7-14.
8Denning DW,Kibbler CC,Barnes RA,et al.British Society for Medical Mycology proposed standards of care for patients with invasive fungal infections.Lancet Infect Dis,2003,3:230-240.
9Pappas PG,Rex JH,Sobel JD,et al.Guidelines for treatment of candidiasis.Clin Infect Dis,2004,38:161-189.
10Slavin MA,Szer J,Grigg AP,et al.Guidelines for the use of antifungal agents in the treatment of invasive Candida and mould infections.Intern Med J,2004,34:192-200.
3Prabhu K,Bhat S,Rao S.Bacteriologic profile and antibio gram of blood culture isolates in a pediatric care unit[J].J Lab Phycicians,2010,2(2):85-88.
4Ruijs GJ,Bloembergen HM,Bruins MJ,et al.Identification and susceptibility testing of Enterobacteriaceae and Pseudomona saaeruginosa by directinocu lation from positive BACTEC blood culturebottles into VITEK2[J].JCl in Microbiol,2004,42(1):7-11.
